{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:59:24Z","timestamp":1790179164018,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673483"],"award-info":[{"award-number":["81673483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003512","name":"State Administration of Foreign Experts Affairs","doi-asserted-by":"publisher","award":["111-2-07"],"award-info":[{"award-number":["111-2-07"]}],"id":[{"id":"10.13039\/501100003512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.peptides.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T12:23:08Z","timestamp":1542198188000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Inhibition of peptide BF-30 on influenza A virus infection in vitro\/vivo by causing virion membrane fusion"],"prefix":"10.1016","volume":"112","author":[{"given":"Jun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingman","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2018.10.004_bib0005","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1021\/jm5014067","article-title":"Discovery of pentacyclic triterpenoids as potential entry inhibitors of influenza viruses","volume":"57","author":"Yu","year":"2014","journal-title":"J. Med. Chem."},{"issue":"684","key":"10.1016\/j.peptides.2018.10.004_bib0010","article-title":"Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza a (H7N9) pandemic","volume":"160","author":"Khazeni","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.peptides.2018.10.004_bib0015","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.peptides.2018.10.004_bib0020","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.3390\/v7102883","article-title":"Perspective of use of antiviral peptides against influenza virus","volume":"7","author":"Skalickova","year":"2015","journal-title":"Viruses Basel"},{"key":"10.1016\/j.peptides.2018.10.004_bib0025","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1099\/vir.0.038679-0","article-title":"A novel family of peptides with potent activity against influenza A viruses","volume":"93","author":"Nicol","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.peptides.2018.10.004_bib0030","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.peptides.2010.07.028","article-title":"A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes","volume":"31","author":"Dean","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2018.10.004_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bpc.2018.01.001","article-title":"The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity","volume":"234","author":"Zabrodskaya","year":"2018","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.peptides.2018.10.004_bib0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.peptides.2011.04.002","article-title":"The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity","volume":"32","author":"Zhou","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2018.10.004_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/molecules23020497","article-title":"Characterization, stability and biological activity in vitro of cathelicidin-BF-30 loaded 4-arm-star-shaped PEG-PLGA microspheres","volume":"23","author":"Bao","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.peptides.2018.10.004_bib0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12272-013-0248-6","article-title":"BF-30 effectively inhibits ciprofloxacin-resistant bacteria in vitro and in a rat model of vaginosis","volume":"37","author":"Wang","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.peptides.2018.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.028","article-title":"BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice","volume":"707","author":"Wang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2018.10.004_bib0060","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3892\/or.2013.2693","article-title":"The cathelicidin-BF Lys(16) mutant Cbf-K-16 selectively inhibits non-small cell lung cancer proliferation in vitro","volume":"30","author":"Tian","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.peptides.2018.10.004_bib0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/psc.2488","article-title":"Effective antimicrobial activity of Cbf-K-16 and Cbf-A(7)A(13) against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro","volume":"19","author":"Hao","year":"2013","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.peptides.2018.10.004_bib0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2016.01.011","article-title":"Antiviral activity of SA-2 against influenza A virus in vitro\/vivo and its inhibition of RNA polymerase","volume":"127","author":"Yu","year":"2016","journal-title":"Antivir Res."},{"key":"10.1016\/j.peptides.2018.10.004_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.01.015","article-title":"A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment","volume":"104","author":"Hoffmann","year":"2014","journal-title":"Antivir Res."},{"key":"10.1016\/j.peptides.2018.10.004_bib0080","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chem."},{"key":"10.1016\/j.peptides.2018.10.004_bib0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4161\/viru.2.6.18148","article-title":"2009 pandemic H1N1 influenza A virus strains display differential pathogenicity in C57BL\/6J but not BALB\/c mice","volume":"2","author":"Otte","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.peptides.2018.10.004_bib0090","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00705-014-2192-2","article-title":"Antiviral activity of baicalin against influenza A (H1N1\/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase","volume":"159","author":"Ding","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.peptides.2018.10.004_bib0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/psc.1007","article-title":"What can light scattering spectroscopy do for membrane-active peptide studies","volume":"14","author":"Domingues","year":"2008","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.peptides.2018.10.004_bib0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1232552","article-title":"Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.peptides.2018.10.004_bib0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ng1072","article-title":"Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis","volume":"33","author":"Takeuchi","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.peptides.2018.10.004_bib0110","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/JVI.00896-14","article-title":"A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans","volume":"88","author":"Colpitts","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2018.10.004_bib0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.peptides.2013.07.014","article-title":"A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses","volume":"48","author":"Sample","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2018.10.004_bib0120","doi-asserted-by":"crossref","first-page":"l","DOI":"10.1111\/j.1574-695X.1995.tb00071.x","article-title":"Study of n.eUtralizing monoclonal antibodies to bovine herpes virus Type-1 (Cooper strain) by immunoperoxidase and immunoelectron microscopy","volume":"11","author":"Winkler","year":"1995","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.peptides.2018.10.004_bib0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biomaterials.2016.02.011","article-title":"Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria","volume":"87","author":"Ma","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.peptides.2018.10.004_bib0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17460441.2012.674510","article-title":"Screening methods for influenza antiviral drug discovery","volume":"7","author":"Atkins","year":"2012","journal-title":"Expert Opin. Drug Dis."},{"key":"10.1016\/j.peptides.2018.10.004_bib0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.peptides.2018.10.004_bib0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plipres.2011.12.005","article-title":"Role of lipids in the interaction of antimicrobial peptides with membranes","volume":"51","author":"Teixeira","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.peptides.2018.10.004_bib0145","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1046\/j.1432-1033.2001.02494.x","article-title":"Amphipathic alpha helical antimicrobial peptides - A systematic study of the effects of structural and physical properties on biological activity","volume":"268","author":"Giangaspero","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.peptides.2018.10.004_bib0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chom.2010.05.008","article-title":"Cellular networks involved in the influenza virus life cycle","volume":"7","author":"Watanabe","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.peptides.2018.10.004_bib0155","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiu353","article-title":"The R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A\/Shanghai\/1\/2013 (H7N9) influenza virus in ferrets","volume":"210","author":"Yen","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.peptides.2018.10.004_bib0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2010.09.008","article-title":"Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel","volume":"401","author":"Pielak","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978118301888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978118301888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:23:16Z","timestamp":1759310596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978118301888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":32,"alternative-id":["S0196978118301888"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2018.10.004","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of peptide BF-30 on influenza A virus infection in vitro\/vivo by causing virion membrane fusion","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}